Search by Drug Name or NDC

    NDC 00067-8114-12 Lamisil AT 1 g/100g Details

    Lamisil AT 1 g/100g

    Lamisil AT is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is TERBINAFINE HYDROCHLORIDE.

    Product Information

    NDC 00067-8114
    Product ID 0067-8114_e076139d-60e6-4e93-81b0-aacebf68cbfb
    Associated GPIs 90150087103710
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Lamisil AT
    Proprietary Name Suffix for Jock Itch
    Non-Proprietary Name Terbinafine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 1
    Active Ingredient Units g/100g
    Substance Name TERBINAFINE HYDROCHLORIDE
    Labeler Name GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
    Pharmaceutical Class Allylamine Antifungal [EPC], Allylamine [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077511
    Listing Certified Through 2024-12-31

    Package

    NDC 00067-8114-12 (00067811412)

    NDC Package Code 0067-8114-12
    Billing NDC 00067811412
    Package 1 TUBE in 1 CARTON (0067-8114-12) / 12 g in 1 TUBE
    Marketing Start Date 2007-07-02
    NDC Exclude Flag N
    Pricing Information N/A
    << 00067-8106-04 00067-8116-04 >>

    Contents

    Standard Product Labeling (SPL)/Prescribing Information SPL 42401fc5-ae6b-405f-a3c5-7c133be0b02f Details

    Revised: 12/2020
    Document Id: e076139d-60e6-4e93-81b0-aacebf68cbfb
    Set id: 42401fc5-ae6b-405f-a3c5-7c133be0b02f
    Version: 4
    Effective Time: 20201217